Schedule 13D ownership disclosure

TALARIS THERAPEUTICS INC

Security class unavailable · CUSIP: 87410C104

Event date: 2021-05-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-169315
Form type
SC 13D
Filer
Longitude Capital Partners III, LLC
CIK
CIK 1713663
Filed
May 21, 2021
Reporting period
May 11, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub